Could a bionic pancreas simplify diabetes care in your Doctor's office?
NCT ID NCT07011147
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares the iLet Bionic Pancreas, an automated insulin delivery system, to standard care for adults with type 1 or type 2 diabetes who use insulin. About 240 participants will use the device for 13 weeks or continue their usual routine. The goal is to see if the device improves blood sugar control and is safe when prescribed by primary care providers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- iLet Bionic Pancreas device
- What this could lead to
- If successful, this could make advanced insulin delivery technology more accessible through primary care, improving blood sugar control for many people with diabetes.
- What could go wrong
- This is a relatively small, 13-week study in primary care, so results may not apply to all patients or settings. The device may not work as well for everyone, and there are risks of low blood sugar or device issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
NOT_YET_RECRUITINGBoston, Massachusetts, 02114, United States
-
University of Colorado Anschutz Medical Campus
RECRUITINGAurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Electric pulse therapy in the gut: a new hope for type 2 diabetes?
- Could a treadmill routine sharpen the diabetic brain?
- Can a weekly shot reverse type 2 diabetes?
- Could a simple questionnaire transform diabetes consultations?
- Fat cell 'Messages' may harm blood vessels — can exercise or surgery stop them?
- Daily pill could offer new hope for weight loss in east asian adults